Prognostic Significance of C-Reactive Protein in Unresectable Hepatocellular Carcinoma treated with Atezolizumab and Bevacizumab.

Shun KanekoYasuhiro AsahinaMiyako MurakawaShunsuke UeyamaChiaki MaeyashikiHideki WatanabeAkiko Kusano-KitazumeAyako SatoKozue UchidateTakehito AsakawaSho WatanabeYasuhiro IizukaIsamu ShibataShinya OookaYuko KarakamaTakashi FujiiTaro WatabeKeiichi AkahoshiMinoru TanabeKento InadaTomohiro MochidaKeiya WatakabeTaro ShimizuJun TsuchiyaMasato MiyoshiFukiko Kitahata-KawaiSayuri NittaMina NakagawaSei KakinumaRyuichi Okamotonull null

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2023)

CRP was a significant biomarker in patients treated with ATZ + BEV for HCC. Elevated CRP levels may indicate aggressive cancer progression and potential resistance to ATZ + BEV therapy. This article is protected by copyright. All rights reserved.

Keyphrases

papillary thyroid
squamous cell
locally advanced
metastatic colorectal cancer
squamous cell carcinoma
human health
radiation therapy
mesenchymal stem cells
climate change
smoking cessation